Scholars requires JavaScript. Please enable it in your browser to view this page.
Skip to main content
Scholars
Weill Cornell Medicine
Browse
About
Sign in
Loading co-authored publications…
Feedback
Scholars
/
Joseph Reginald Osborne, MD, PhD
/
Co-authored with Valentina Marulanda Corzo
Co-authored publications
Joseph Reginald Osborne, MD, PhD and Valentina Marulanda Corzo · 12 publications
CSV
Word
Abstract CT305: Fractionated (dose dense) and multiple dose PSMA-targeted alpha emitter 225Ac-J591 for advanced prostate cancer: Final primary and secondary outcomes
Cancer Research
· 2026
Source: OpenAlex
·
DOI
Imaging meets genomics in treatment-naïve prostate cancer: SUVmax on prostate-specific membrane antigen (PSMA) PET as a biomarker of genomic classifier risk.
Journal of Clinical Oncology
· 2026
Source: OpenAlex
·
DOI
Brain-Specific Quantification of Somatostatin Receptor Expression: SUV
max
and SUVR
sss
as Quantitative Correlates of the Krenning Score in Meningioma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
· 2026
JR
Joseph Reginald Osborne
VM
Valentina Marulanda Corzo
MF
Michael Farid
TH
Trevor Hill
+8 more →
JI
Jana Ivanidze
PMID:
42880959
·
DOI
·
Abstract
A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti-PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
· 2026
JR
Joseph Reginald Osborne
VM
Valentina Marulanda Corzo
ST
Scott T. Tagawa
CT
Charlene Thomas
AB
Abdul Baseet Arham
+12 more →
PMID:
42485097
·
PMCID:
PMC13579537
·
DOI
·
2 citations
·
Abstract
How Will PSMAddition Impact the Management of Prostate Cancer?
European urology focus
· 2026
JR
Joseph Reginald Osborne
VM
Valentina Marulanda Corzo
AN
Aaron N Holmes
ST
Scott T. Tagawa
PMID:
42276910
·
DOI
·
3 citations
·
Abstract
Top advances of the year: Radiopharmaceutical therapy for prostate cancer.
Cancer
· 2026
JR
Joseph Reginald Osborne
VM
Valentina Marulanda Corzo
PK
Preeti Kakkar
SH
Sandra Huicochea Castellanos
ST
Scott T. Tagawa
PMID:
42216431
·
DOI
·
Abstract
PSMA-PET Total Tumor Volume Response: Ready for Prime Time or a Work in Progress?
European urology
· 2026
JR
Joseph Reginald Osborne
VM
Valentina Marulanda Corzo
ST
Scott T. Tagawa
PMID:
42128754
·
DOI
Clinical Utility of [
18
F]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma.
AJNR. American journal of neuroradiology
· 2026
JR
Joseph Reginald Osborne
VM
Valentina Marulanda Corzo
JI
Jana Ivanidze
KV
Kellen Vo Vu
AB
Andrew Brandmaier
+11 more →
PMID:
41326230
·
PMCID:
PMC13020911
·
DOI
·
5 citations
·
Abstract
Revolutionizing prostate cancer treatment: Prostate Specific Membrane Antigen (PSMA) targeted therapy in modern therapeutics
Revista Espanola de Medicina Nuclear e Imagen Molecular
· 2025
Source: Scopus
·
DOI
IMG-63. Clinical Utility of 18F-FLUCICLOVINE PET/MRI for Differentiating True Progression from Treatment Effects in Glioblastoma
Neuro-Oncology
· 2025
Source: OpenAlex
·
DOI
Long-term outcomes of active surveillance after DOTATATE PET/MRI-confirmed gross total resection in WHO grade 2 meningioma.
Neuro-oncology advances
· 2025
JR
Joseph Reginald Osborne
VM
Valentina Marulanda Corzo
JI
Jana Ivanidze
KV
Kellen Vo Vu
KR
Kate Rosen
+16 more →
PMID:
41497451
·
PMCID:
PMC12768507
·
DOI
·
1 citations
·
Abstract
Revolutionizing prostate cancer treatment: PSMA-targeted therapy in modern therapeutics.
Revista espanola de medicina nuclear e imagen molecular
· 2025
JR
Joseph Reginald Osborne
VM
Valentina Marulanda Corzo
AR
A Ricaurte-Fajardo
SF
Samuel Francis Ruder
+4 more →
SH
Sandra Huicochea Castellanos
PMID:
40403928
·
DOI
·
Abstract